For example, TNF-α inhibition and IL-1β inhibition have been successful as therapies for rheumatoid arthritis (RA) [8, 9] and chronic inflammatory pathologies associated with cancer [63], respectively. This evidence concerns the gene IL1B and rheumatoid arthritis.